Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2

View ORCID ProfileJoachim Curtius, Manuel Granzin, Jann Schrod
doi: https://doi.org/10.1101/2020.10.02.20205633
Joachim Curtius
Institute for Atmospheric and Environmental Sciences, Goethe University Frankfurt am Main, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joachim Curtius
  • For correspondence: curtius@iau.uni-frankfurt.de
Manuel Granzin
Institute for Atmospheric and Environmental Sciences, Goethe University Frankfurt am Main, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jann Schrod
Institute for Atmospheric and Environmental Sciences, Goethe University Frankfurt am Main, Altenhöferallee 1, 60438 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The airborne transmission of SARS-CoV-2 through virus-containing aerosol particles has been established as an important pathway for Covid-19 infection. Suitable measures to prevent such infections are imperative, especially in situations when a high number of persons convene in closed rooms. Here we tested the efficiency and practicability of operating air purifiers in a high school classroom while regular classes were taking place. Four air purifiers equipped with HEPA filters were installed in a classroom. We monitored the total aerosol number concentration for particles > 3 nm at two locations in the room (uCPC), the aerosol size distribution in the range from 10 nm to 10 µm (SMPS and OPS), aerosol mass (PM10 derived from OPS) as well as the CO2 concentration in the room. For comparison, we performed similar measurements in parallel by operating a uCPC and an OPS in a neighboring class room without air purifiers. The measurements show that in times when classes were conducted with windows and door closed, the aerosol concentration was reduced by more than 90 % within less than 30 minutes when running the purifiers with a volume flow of 1027 m3/h in the classroom with a volume of 186 m3. The reduction was homogeneous throughout the room, as well as homogeneous for all particle sizes. The measurements are supplemented by a basic calculation estimating the maximum concentration levels of virus-containing aerosol from a highly contagious person speaking in a closed room with and without air purifiers. The measurements and the calculation demonstrate that air purifiers represent a well suited measure to reduce the risks of airborne transmission of SARS-CoV-2 substantially. Staying for two hours in a closed room with a super infective person, we estimate that the inhaled dose is reduced by a factor of six when using air purifiers with a total air exchange rate of 5.7 h-1. Nevertheless, in closed rooms with a high person-density frequent ventilation supplying fresh air is necessary to keep the CO2 concentration levels below the maximum permissible values.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The project was conducted with internal financial support only. No funding was received from third parties for any aspect of the submitted work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

n.a.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The original data is available from the corresponding author upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2
Joachim Curtius, Manuel Granzin, Jann Schrod
medRxiv 2020.10.02.20205633; doi: https://doi.org/10.1101/2020.10.02.20205633
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2
Joachim Curtius, Manuel Granzin, Jann Schrod
medRxiv 2020.10.02.20205633; doi: https://doi.org/10.1101/2020.10.02.20205633

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8789)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1863)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10565)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1756)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (265)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1845)
  • Public and Global Health (3986)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)